TK-280

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTK-280
Drug Alias NameTK-280
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsInflammationArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesToyobo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesToyobo Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A